OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
OSSD$4.1558

OssDsign AB

Medical Equipment, Supplies & DistributionVerified

OssDsign AB has a market capitalization of 459.1 million SEK and a price-to-book ratio of 2.04, indicating that the market values the company at a premium to its book value. The company's liquidity position is characterized by a current ratio of 6.33, suggesting strong short-term liquidity, but its operating cash flow of -46.65 million SEK indicates a significant outflow of cash from operations. Profitability metrics show a challenging financial position for OssDsign. The company reported a net loss of 15.69 million SEK and an operating loss of 15.29 million SEK. Return on equity is negative at -6.98%, and return on assets is also negative at -5.12%, both significantly below industry norms for a profitable medical equipment company. Geographically and segment-wise, OssDsign's revenue concentration is not disclosed in the available data. However, the company's operations are primarily in the healthcare services and equipment sector, with no detailed breakdown of revenue by geographic region or product segment provided in the financial snapshot. Looking at the growth trajectory, OssDsign's revenue in the latest period was 29.74 million SEK, with analysts estimating a mean revenue of 199.33 million SEK for the next period. This suggests a potential growth of 575% in revenue, although the company is currently reporting a net loss and negative operating cash flow. The risk assessment for OssDsign indicates a medium liquidity risk and a low dilution risk. The company has a debt-to-equity ratio of 0.01, indicating minimal leverage, but its net cash position is negative after subtracting total debt. The risk of dilution is low, with no significant dilution potential identified in the basic shares outstanding. Recent events and filings show that OssDsign is under analyst coverage with a mean price target of 13.00 SEK, significantly higher than the current market price of 4.15 SEK. The company's earnings per share (EPS) are expected to remain negative, with a mean estimate of -0.36 SEK, slightly improved from the last actual EPS of -0.38 SEK.

30-day price · OSSD-1.96 (-31.8%)
Low$3.33High$6.62Close$4.20As of13 May, 00:00 UTC
Profile
CompanyOssDsign AB
TickerOSSD.ST
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. OssDsign AB is a medical equipment and supplies company that provides healthcare services and equipment, primarily operating in the healthcare sector.

Classification. OssDsign is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a classification confidence of 0.92.

OssDsign AB has a market capitalization of 459.1 million SEK and a price-to-book ratio of 2.04, indicating that the market values the company at a premium to its book value. The company's liquidity position is characterized by a current ratio of 6.33, suggesting strong short-term liquidity, but its operating cash flow of -46.65 million SEK indicates a significant outflow of cash from operations. Profitability metrics show a challenging financial position for OssDsign. The company reported a net loss of 15.69 million SEK and an operating loss of 15.29 million SEK. Return on equity is negative at -6.98%, and return on assets is also negative at -5.12%, both significantly below industry norms for a profitable medical equipment company. Geographically and segment-wise, OssDsign's revenue concentration is not disclosed in the available data. However, the company's operations are primarily in the healthcare services and equipment sector, with no detailed breakdown of revenue by geographic region or product segment provided in the financial snapshot. Looking at the growth trajectory, OssDsign's revenue in the latest period was 29.74 million SEK, with analysts estimating a mean revenue of 199.33 million SEK for the next period. This suggests a potential growth of 575% in revenue, although the company is currently reporting a net loss and negative operating cash flow. The risk assessment for OssDsign indicates a medium liquidity risk and a low dilution risk. The company has a debt-to-equity ratio of 0.01, indicating minimal leverage, but its net cash position is negative after subtracting total debt. The risk of dilution is low, with no significant dilution potential identified in the basic shares outstanding. Recent events and filings show that OssDsign is under analyst coverage with a mean price target of 13.00 SEK, significantly higher than the current market price of 4.15 SEK. The company's earnings per share (EPS) are expected to remain negative, with a mean estimate of -0.36 SEK, slightly improved from the last actual EPS of -0.38 SEK.
Key takeaways
  • OssDsign is trading at a price-to-book ratio of 2.04, indicating a premium to its book value.
  • The company is currently unprofitable, with a net loss of 15.69 million SEK and a negative return on equity of -6.98%.
  • Analysts have a bullish outlook, with a mean price target of 13.00 SEK, suggesting a potential upside of over 200%.
  • The company has a strong current ratio of 6.33 but is experiencing negative operating cash flow.
  • OssDsign's revenue is expected to grow significantly, with a mean estimate of 199.33 million SEK for the next period.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencySEK
Revenue$29.7M
Gross profit$27.7M
Operating income-$15.3M
Net income-$15.7M
R&D
SG&A
D&A
SBC
Operating cash flow-$46.7M
CapEx$0.00
Free cash flow
Total assets$306.5M
Total liabilities$81.6M
Total equity$224.8M
Cash & equivalents
Long-term debt$2.6M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$31.7M-$89.7M-$93.9M-$84.2M
FY-3$57.0M-$96.9M-$99.4M-$89.8M
FY-2$112.2M-$127.6M-$130.5M-$122.4M
FY-1$133.9M-$49.4M-$49.7M-$43.9M
FY0$180.2M-$46.8M-$51.0M-$51.8M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$344.0M$262.7M
FY-3$339.5M$248.1M
FY-2$356.4M$251.1M
FY-1$307.4M$214.1M
FY0$397.9M$310.0M
PeriodOCFCapExFCFSBC
FY-4-$89.6M-$57.0k-$84.2M
FY-3-$86.2M-$129.0k-$89.8M
FY-2-$93.9M-$124.0k-$122.4M
FY-1-$62.4M-$657.0k-$43.9M
FY0-$64.0M-$7.4M-$51.8M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$29.7M-$15.3M-$15.7M
FQ-6$35.7M-$9.8M-$9.8M
FQ-5$41.4M-$12.3M-$13.1M
FQ-4$44.5M-$12.7M-$14.6M
FQ-3$46.5M-$6.9M-$8.3M
FQ-2$44.0M-$5.5M-$5.8M
FQ-1$45.1M-$21.6M-$22.3M
FQ0$36.9M-$13.5M-$11.5M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$306.5M$224.8M
FQ-6$295.6M$214.4M
FQ-5$307.4M$214.1M
FQ-4$285.2M$203.1M
FQ-3$428.0M$343.7M
FQ-2$430.7M$347.3M
FQ-1$397.9M$310.0M
FQ0$377.5M$298.9M
PeriodOCFCapExFCFSBC
FQ-7-$46.7M$0.00
FQ-6-$55.3M-$424.0k
FQ-5-$62.4M-$657.0k
FQ-4-$25.9M-$1.3M
FQ-3-$37.8M-$3.2M
FQ-2-$49.4M-$4.9M
FQ-1-$64.0M-$7.4M
FQ0-$14.9M-$6.0M
Valuation
Market price$4.15
Market cap$459.1M
Enterprise value$461.7M
P/E
Reported non-GAAP P/E
EV/Revenue15.5
EV/Op income
EV/OCF
P/B2.0
P/Tangible book2.0
Tangible book$224.8M
Net cash-$2.6M
Current ratio6.3
Debt/Equity0.0
ROA-5.1%
ROE-7.0%
Cash conversion3.0%
CapEx/Revenue0.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 369 companies
MetricOSSDActivity
Op margin-51.4%3.9% medp25 -31.3% · p75 14.4%bottom quartile
Net margin-52.8%2.4% medp25 -30.5% · p75 11.1%bottom quartile
Gross margin93.2%46.7% medp25 28.2% · p75 63.1%top quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue0.0%-4.8% medp25 -11.6% · p75 -2.4%top quartile
Debt / equity1.0%17.9% medp25 2.7% · p75 52.2%bottom quartile
Observations
IR observations
Mean price target13.00 SEK
Median price target12.00 SEK
High price target15.00 SEK
Low price target12.00 SEK
Mean EPS estimate-0.36 SEK
Last actual EPS-0.38 SEK
Mean revenue estimate199,333,330 SEK
Last actual revenue180,159,000 SEK
Mean EBIT estimate-42,666,670 SEK
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-16 17:32 UTC#d897d535
Market quoteclose SEK 4.01 · shares 0.11B diluted
no public URL
2026-05-12 02:14 UTC#cd2e9a81
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 21:31 UTCJob: e646ea89